Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries

B Godman, H McCabe, TD Leong… - Expert review of …, 2020 - Taylor & Francis
Introduction There are positive aspects regarding the prescribing of fixed dose combinations
(FDCs) versus prescribing the medicines separately. However, these have to be balanced …

[HTML][HTML] Meta-analysis of studies comparing single and multi-tablet fixed dose combination HIV treatment regimens

PG Clay, S Nag, CM Graham, S Narayanan - Medicine, 2015 - journals.lww.com
Availability of a single source review of once-daily fixed-dose single tablet regimen (STR)
and multiple tablet fixed-dose regimen (MTR) would optimally inform healthcare providers …

[HTML][HTML] A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV

PG Clay, WC Yuet, CH Moecklinghoff… - AIDS Research and …, 2018 - Springer
Objectives To compare outcomes with single tablet regimens (STR) versus multi-tablet
regimens (MTR) for human immunodeficiency virus (HIV) treatment using published data …

[HTML][HTML] Evidence of high out of pocket spending for HIV care leading to catastrophic expenditure for affected patients in Lao People's Democratic Republic

H Barennes, A Frichittavong, M Gripenberg, P Koffi - PLoS One, 2015 - journals.plos.org
Background The scaling up of antiviral treatment (ART) coverage in the past decade has
increased access to care for numerous people living with HIV/AIDS (PLWHA) in low …

De‐simplifying single‐tablet antiretroviral treatments: uptake, risks and cost savings

HB Krentz, S Campbell, M Lahl, MJ Gill - HIV medicine, 2019 - Wiley Online Library
Objectives As more HIV‐positive individuals receive antiretroviral therapy (ART), payers are
seeking options for covering these increased and sustained drug costs. Strategic use of …

Budget impact of antiretroviral therapy in a French clinic cohort

E Papot, R Landman, F Louni, C Charpentier… - Aids, 2017 - journals.lww.com
Objectives: In this study, we first assessed costs associated with the use of antiretroviral
therapy (ART) in an infectious diseases University Hospital Clinic; second, we evaluated …

[HTML][HTML] Patient-reported outcomes among people living with HIV on single-versus multi-tablet regimens: Data from a real-life setting

S Degroote, L Vandekerckhove, D Vogelaers… - Plos one, 2022 - journals.plos.org
Background The use of single-tablet regimens (STRs) in HIV treatment is ubiquitous.
However, reintroducing the (generic) components as multi-tablet regimens (MTRs) could be …

[HTML][HTML] New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service …

U Restelli, F Scolari, P Bonfanti, D Croce… - BMC infectious …, 2015 - Springer
Background In the healthcare sector, it is crucial to identify sustainable strategies in order to
allow the introduction and use of innovative technologies. Now, and over the next few years …

Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: impact of generic antiretroviral drugs on cost reduction

J Rwagitinywa, A Sommet, A Palmaro, JL Montastruc… - Health Policy, 2018 - Elsevier
Introduction Simulation studies showed that generic antiretroviral (ARV) drug utilization
could lead to significant cost reduction of HIV treatment in developed world. This study …

Patient perspectives on de‐simplifying their single‐tablet co‐formulated antiretroviral therapy for societal cost savings

HB Krentz, S Campbell, VC Gill, MJ Gill - HIV medicine, 2018 - Wiley Online Library
Objectives The incremental costs of expanding antiretroviral (ARV) drug treatment to all HIV‐
infected patients are substantial, so cost‐saving initiatives are important. Our objectives …